Thursday, December 28, 2017 12:17:01 PM
I would guess based on the last PR, they will conduct another Phase 3 specifically directed at the subgroups, or maybe the FDA provided Guidance that they can continue to file for Acceptance based on the data of the subgroups alone. Regardless of the primary endpoints not being met, the subgroups performed amazingly!
Here's to looking for a golden 2018!
Best Of Luck!
IMHO
In My Own Personal Opinion Of Course!
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM